ACER - Why Is Acer Therapeutics Stock Trading Higher Today? | Benzinga
Zevra Therapeutics Inc (NASDAQ: ZVRA) has agreed to acquire Acer Therapeutics Inc (NASDAQ: ACER) for up to $91 million. The transaction is expected to close in Q4 2023.
The deal consideration includes approximately 2.96 million shares of Zevra common stock valued at $15 million and up to an additional $76 million in a series of potential cash payments according to non-transferable Contingent Value Rights (CVRs) upon achievement of certain commercial and regulatory milestones for Acer's ...